Related Experiment Video
Updated: May 16, 2025
Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
CDC42 Regulatory Patterns Related To Inflammatory Bowel Disease and Hyperglycemia
Marija Stojanovic1,2, Devendra K Agrawal1
1Department of Translational Research, Western University of Health Sciences, Pomona, California 91766, USA.
Abstract:
As a member of the rat sarcoma virus homolog (Rho) guanosine triphosphatases (GTPases) family, Cdc42 represents a "switch" molecule, by changing from inactive (GDP-associated) to active form (GTP-associated) and vice versa. Cdc42 is activated by the guanine nucleotide exchange factors (GEFs), in contrast to GTPase-activating proteins (GAPs) which are responsable for formation of GDP-binding, inactive form of Cdc42. Some of the fundamental cellular functions are regulated by Cdc42 such as cytosceleton dynamics, cell cycling, transcription and cellular trafficking. In the gastrointestinal system, Cdc42 participates in maintenance of the functional epithelial barrier by controling intestinal epithelial cell polarity and interconnections. In addition, Cdc42 expression in pancreatic β-cells is of great importance for glucose-stimulated insulin secretion. From the pathophysiological point of view, literature data provide some evidence for Cdc42 sigaling in inflammatory bowel disease, as well as in hyperglycemic conditions related to diabetes mellitus. However, whether and by which mechanism Cdc42 contributes to the IBD patophysiology in hyperglycemic conditions is still not fully understood. Therefore, we performed bioinformatics analysis to predict transcriptional factor-gene interactions related to Cdc42 signaling in inflammatory bowel disease in hyperglycemic conditions. In silico analysis predicts various interactions between input genes and output transcriptional factors, and therefore reveals the molecules with the highest predicted effect on particular genes. Based on the predictive interactions with the intracellular molecules, carefully designed in vitro or in vivo studies are required to get better insight in the pathways of interest. Better understanding of Cdc42 molecular pathway in inflammatory bowel disease and hyperglycemia will help identifying potential targets for therapeutical modifications in clinical setting resulting in better control of the disease progression.
Insights
Cdc42, a key regulator of cell functions, is implicated in inflammatory bowel disease (IBD) and hyperglycemia. Bioinformatics analysis predicted gene interactions, suggesting potential therapeutic targets for managing IBD in diabetic conditions.
Area of Science:
- Molecular Biology
- Cell Biology
- Bioinformatics
Background:
- Cdc42 is a Rho GTPase regulating fundamental cellular processes like cytoskeleton dynamics and cell polarity.
- Cdc42 plays roles in gastrointestinal epithelial barrier function and insulin secretion.
- Evidence suggests Cdc42 signaling in inflammatory bowel disease (IBD) and hyperglycemia (diabetes mellitus).
Purpose of the Study:
- To investigate the role of Cdc42 signaling in the pathophysiology of inflammatory bowel disease under hyperglycemic conditions.
- To predict transcriptional factor-gene interactions related to Cdc42 signaling in IBD and hyperglycemia using bioinformatics analysis.
Main Methods:
- Bioinformatics analysis was employed to predict transcriptional factor-gene interactions.
- In silico analysis identified key molecules influencing Cdc42-related gene expression.
Main Results:
- The study predicted various interactions between genes and transcriptional factors involved in Cdc42 signaling.
- In silico analysis revealed molecules with significant predicted effects on specific genes within the context of IBD and hyperglycemia.
Conclusions:
- Understanding Cdc42's molecular pathway in IBD and hyperglycemia is crucial.
- Predicted interactions highlight potential therapeutic targets for disease management and control.
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
01:20The JAK-STAT Signaling Pathway